Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions

This study highlights the biomarker-guided precision medicine strategy for drug repurposing. Pitavastatin and atorvastatin could be used to assist in the treatment of advanced CRC, particularly with CMS4 subtype CRC patients who also suffer from hyperglycemia. Pitavastatin, with an achievable dosage used for clinical interventions, is highly recommended for a novel CRC therapeutic strategy.

Authors

Institutions

Publication Details

Journal
Cancer Cell International
Published
2025-03-06
DOI
https://doi.org/10.1186/s12935-025-03712-2
Citations
9
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
8.43

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions

Chi‐Ying F. Huang, Tai‐Shan Cheng, Yi‐Shiou Chiou, Sin-Yu Chen et al.
9 citations
Cancer Cell International
Cancer, Lipids, and Metabolism
8.43
article

Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions

Chi‐Ying F. Huang, Tai‐Shan Cheng, Yi‐Shiou Chiou, Sin-Yu Chen, Wei-Ming Cheng, Thi‐Huong Nguyen, Yu‐Feng Hu, Ying Chang, Tzu-Yi Huang, Po-Chen Li, Chih‐Wei Wu, Hsiao‐Sheng Liu, Ming‐Fen Lee, Jinmei Lai, Yu‐Tang Huang, Peter Mu‐Hsin Chang, Thu-Ha Tran, Yi‐Ren Hong, Minh Tran-Binh Nguyen, Thu-Huyen Hoang, Yu-Chieh Chu, Yu-Teng Lin
article en
9 citations

Abstract

This study highlights the biomarker-guided precision medicine strategy for drug repurposing. Pitavastatin and atorvastatin could be used to assist in the treatment of advanced CRC, particularly with CMS4 subtype CRC patients who also suffer from hyperglycemia. Pitavastatin, with an achievable dosage used for clinical interventions, is highly recommended for a novel CRC therapeutic strategy.

Cancer Cell InternationalVol. 25(1)
Fu Jen Catholic University (TW), National Yang Ming Chiao Tung University (TW), Kaohsiung Medical University (TW), China Medical University (TW), Kaohsiung Medical University Chung-Ho Memorial Hospital (TW), Taipei Veterans General Hospital (TW), Genomics Research Center, Academia Sinica (TW), Institute of Biomedical Sciences, Academia Sinica (TW), Far Eastern Memorial Hospital (TW), Taipei City Hospital (TW), Thai Nguyen University of Agriculture and Forestry (VN), Oxford University Clinical Research Unit (VN), Academia Sinica (TW), Stanford University (US)
China Medical University, Taiwan, Department of Health, Taipei City Government
Good health and well-being
Openalex Percentile: Top 2%
Cancer, Lipids, and Metabolism
8.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.